VOTUBIA cpr 2.5 mg 30 pce
7680620610013
CH-62061
L01XE10
07.16.4.
Reimbursement limitations:
VOTUBIA2
Chez les patients atteints de sclérose tubéreuse:
- pour le traitement d’astrocytomes sous-épendymaires à cellules …
1 / 3
google
Details
- Product number
- 6206101
- CPT
- -
- Packaging group
- 30
- Unit
- Tablette(n)
- Composition
- everolimusum 2.5 mg, magnesii stearas, lactosum monohydricum 2.45 mg, hypromellosum, crospovidonum, lactosum 71.875 mg, E 321 pro compresso.
Articles (1)
Votubia 2.5 mg, Tabletten
Tabletten
30
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
2.5 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
2.45 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
71.875 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | ANTOX |
Reimbursement information
Public price
CHF 1254.85
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/10/2011
Authorization holder
Novartis Pharma Schweiz AG
6343 Risch
Authorization information
- Swissmedic authorization number
- 62061
- Drug name
- Votubia, Tabletten
- Galenic form
- TAB
- ATC Code
- L01XE10
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 06/05/2011
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.4.
- Domain
- Human medicine
Packaging details
- Description (FR)
- VOTUBIA cpr 2.5 mg 30 pce
- Description (DE)
- VOTUBIA Tabl 2.5 mg 30 Stk
- Market launch
- 06/05/2011
- Narcotic (BTM)
- No